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Many currently utilized chemotherapeutic drugs create 
considerable toxic side effects when used in the clinic. 
Research into formulating these drugs as nanocrystals is 
a developing field with the intent of reducing systemic 
toxicity while increasing drug efficacy. While pure 
nanocrystals inherently promote the drug concentration 
within a tumor, research into whether surface coating of 
drug nanocrystals enhances treatment efficacy is ongoing. 
Through experiments utilizing the Sulforhodamine B 
(SRB) method, we tested various surface-coated paclitaxel 
nanocrystals to determine any enhancement by the surface 
coating to the cytotoxicity of the drug. An IC50 (i.e., the 
drug concentration to inhibit 50% growth of cancer cells) 
assay was chosen to determine the cytotoxicity value for 
each surface-coated formulation on two different cancer 
cell lines. These in vitro experiments assessed the efficacy 
of paclitaxel liquid formulation, paclitaxel nanocrystals, 
and five different, strategically selected polymer-coated 
paclitaxel nanocrystals that were intended to target 
overexpressed membrane receptors by cancer cells. It was 
determined that paclitaxel nanocrystals indeed showed a 
higher cytotoxicity than the conventional paclitaxel liquid 
formulation at comparable incubation times. Additionally, 
polymer-coated nanocrystals had higher cytotoxicity than 
pure nanocrystals of all concentrations except for the 
highest tested. The cytotoxicity data is encouraging in that 
there are more ways to increase cytotoxicity while ideally 
reducing systemic toxicity for chemotherapy. Both in vitro 
and in vivo studies are underway to further investigate 
cellular uptake mechanisms and pharmacokinetics of the 
surface-treated drug nanocrystals.
Research advisor Tonglei Li writes, “Alexandra’s project 
provided further support for our nanocrystal-based 
delivery systems for cancer treatment. She was able to 
determine the cytotoxicity of various surface-treated 
nanocrystals of a chemotherapeutic agent. The results 
enabled us to pursuit animal studies helping our research 
to be translated into clinical applications.”
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